Purpose: Limited research has been published on the effect of piezo‐assisted intracytoplasmic sperm injection (P‐ICSI). We evaluated the effect of P‐ICSI on the laboratory, clinical, and neonatal outcomes.Methods: This retrospective study was based on the data collected between April 2011 and October 2016. Total 1348 mature oocytes from 145 patients were analyzed. Laboratory, clinical, and neonatal outcomes of those given conventional intracytoplasmic sperm injection (C‐ICSI) and those administered P‐ICSI were examined.Results: P‐ICSI showed significantly more favorable results, with a survival rate of 97.0% (C‐ICSI: 94.1%, P < .010) and a fertilization rate of 83.5% (C‐ICSI: 70.6%, P < .001). There were no differences in the blastocyst development rate, implantation rate, miscarriage rate, live birth rate, gestational age, birth weight, proportion of male neonates, cesarean section rate, and congenital abnormalities between the two patient groups.Conclusions: Our comparison of P‐ICSI with C‐ICSI showed that P‐ICSI significantly improved the survival and fertilization.
Conventional freezing procedures are not appropriate for surgically retrieved spermatozoa from the epididymis or testis because of their low numbers. Techniques for the cryopreservation of small numbers of spermatozoa have not been fully established. We tried to develop a cryopreservation method for a single spermatozoon using Cryotop, which has a simple structure and is easy to handle. Different parameters influencing the freezing procedure, types of container, sources of spermatozoa, and cryoprotectants were evaluated. The sperm recovery rate after thawing was similar between the sperm frozen using Cryotop or zona pellucida as containers (98.0% vs. 88.0%). Freezing of motile single spermatozoa obtained from ejaculates and testes were evaluated for recovery rate (90.0% vs. 95.0%) and motility rate (44.4% vs. 42.1%), which were not significantly different. The survival rate was significantly higher when sperm were treated with sucrose rather than with SpermFreeze (65.3% vs. 37.3%, P < 0.01). Cry...
Signal transducer and activator of transcription 5 (StatS) regulates growth, differentiation, and survival of mammary and hematopoietic cells. The role of Stat5 in breast cancer has not been established, although Stat5 is critical for some hematopoietic maignancies. In this study, we have analyzed the role of Stat5 in progression of the estrogen receptor‐positive T47D human breast cancer cell line, in which Stat5b is constitutively activated. Expression of Stat5‐regulated genes, such as cyclin D1 and bcl‐xL, was strongly suppressed in T47D cells infected with the dominant‐negative Stat5 adenovirus, AdStat5aA740. We also determined the phenotypic effects of introduction of dominant‐negative Stat5 on T47D‐derived tumors in nude mice. Tumors injected with AdStat5aA740 showed a 60% reduction in size, which was associated with the induction of apoptosis. Our results indicate the possibility of using dominant‐negative Stat5 to induce apoptosis in certain Stat5‐activated breast cancers.